ArticleBlood cancer journal2023

Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia.

Keyuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.